原发性肝癌放疗的指南推荐解读

doi:10.3760/cma.j.issn.1004-4221.2018.05.021

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

基于循证医学证据的治疗指南为临床肿瘤医生提供了较为合理的治疗策略推荐。目前,巴塞罗那临床肝癌(BCLC)、欧洲肝病研究学会及欧洲癌症治疗研究组织(EASL-EORTC)、美国肝病研究学会(AASLD)、美国国家综合癌症网络(NCCN)、亚太地区原发性肝癌专家(APPLE)、韩国肝癌研究组及国立癌症中心(KLCSG-NCC)和中华医学会放射肿瘤治疗学分会(CSTRO)等国内外多个组织均发布了原发性肝癌治疗指南。尽管肝癌放疗在临床上早已广泛开展,但是却未被一部分指南推荐。本文拟对国内外指南中针对放疗的推荐进行解读,探讨肝癌放疗的现状和未来前景。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨咏强
	田野

关键词 ：肝肿瘤/放射疗法, 共识

Abstract：

The treatment guidelines based on evidence-based medical evidence provide appropriate treatment strategies for clinical oncologists. Currently, many treatment guidelines for primary liver cancer have been published and updated by many organizations from different countries, including Barcelona Clinic Liver Cancer (BCLC), European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL-EORTC), American Association for the Study of Liver Diseases (AASLD), National Comprehensive Cancer Network (NCCN), Asia-Pacific Primary Liver Cancer Expert (APPLE), Korean Liver Cancer Study Group and National Cancer Center (KLCSG-NCC), and Chinese Society for Therapeutic Radiology and Oncology (CSTRO), Chinese Medical Association. Although radiotherapy is commonly used in clinical practice, some guidelines do not accept it as a standard treatment strategy. In this article, we review the current treatment guidelines and discuss the current status and future prospects of radiotherapy in the management of primary liver cancer.

Key words： Liver neoplasms/radiotherapy Consensus

收稿日期: 2017-11-08

基金资助:

苏州市“科教兴卫”青年科技项目(KJXW2016010);江苏省医学创新团队A类(CXDT-37);苏州市科技发展计划(SZS201509);苏州市临床医学中心建设项目(Szzxj201503);姑苏卫生领军人才(62)

通讯作者: 田野,Email:dryetian@126.com

引用本文:

杨咏强,田野. 原发性肝癌放疗的指南推荐解读[J]. 中华放射肿瘤学杂志, 2018, 27(5): 538-541.

Yang Yongqiang,Tian Ye. A review of updated guidelines for radiotherapy for primary liver cancer[J]. Chinese Journal of Radiation Oncology, 2018, 27(5): 538-541.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2018.05.021 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2018/V27/I5/538

[1]Forner A,Reig ME,De Lope CR,et al. Current strategy for staging and treatment:the BCLC update and future prospects[J].Semin Liver Dis,2010,30(1):61-74.DOI:10.1055/s-0030-1247133.
[2]European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J].Eur J Cancer,2012,48(5):599-641.DOI:10.1016/j.ejca.2011.12.021.
[3]Bruix J,Sherman M.Management of hepatocellular carcinoma:an update[J].Hepatology,2011,53(3):1020-1022.DOI:10.1002/hep.24199.
[4]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Hepatobiliary cancers[DB/OL].Fort Washington,PA:National Comprehensive Cancer Network[2018-02-14].https://www.nccn.org/professionals/physician_gls/default.aspx#site.
[5]Park HC,Yu JI,Cheng JCH,et al. Consensus for radiotherapy in hepatocellular carcinoma from the 5^th Asia-Pacific Primary Liver Cancer Expert meeting (APPLE 2014):current practice and future clinical trials[J].Liver Cancer,2016,5(3):162-174.DOI:10.1159/000367766.
[6]Korean Liver Cancer Study Group (KLCSG),National Cancer Center,Korea (NCC).2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma[J].Korean J Radiol,2015,16(3):465-522.DOI:10.3348/kjr.2015.16.3.465.
[7]中华医学会放射肿瘤学分会,中国生物医学工程学会精确放疗分会肝癌学组与消化系统肿瘤专家委员会,中国研究型医院学会放射肿瘤学分会肝癌学组.2016年原发性肝癌放疗共识[J].中华放射肿瘤学杂志,2016,25(11):1141-1150.DOI:10.3760/cma.j.issn.1004-4221.2016.11.001.
Radiation Oncology Branch of the Chinese Medical Association,Expert Committee on Liver Cancer and Digestive System of China Institute of Biomedical Engineering,Liver Cancer Research Group of Radiation Oncology Branch of China Research Hospital. Consensus on radiation therapy for primary liver cancer in 2016[J].Chin J Radiat Oncol,2016,25(11):1141-1150.DOI:10.3760/cma.j.issn.1004-4221.2016.11.001.
[8]Qi WX,Fu S,Zhang Q,et al. Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma:a systematic review and meta-analysis[J].Radiother Oncol,2015,114(3):289-295.DOI:10.1016/j.radonc.2014.11.033.
[9]Im JH,Yoon SM,Park HC,et al. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area[J].Liver Int,2017,37(1):90-100.DOI:10.1111/liv.13191.
[10]Huo YR,Eslick GD.Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma:a systematic review and meta-analysis[J].JAMA Oncol,2015,1(6):756-765.DOI:10.1001/jamaoncol.2015.2189.
[11]Meng MB,Cui YL,Lu Y,et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma:a systematic review and meta-analysis[J].Radiother Oncol,2009,92(2):184-194.DOI:10.1016/j.radonc.2008.11.002.
[12]Zhang T,Zhao YT,Wang Z,et al. Efficacy and safety of intensity-modulated radiotherapy following transarterial chemoembolization in patients with unresectable hepatocellular carcinoma[J].Medicine,2016,95(21):e3789.DOI:10.1097/MD.0000000000003789.
[13]Hou JZ,Zeng ZC,Zhang JY,et al. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion[J].Int J Radiat Oncol Biol Phys,2012,84(2):362-368.DOI:10.1016/j.ijrobp.2011.12.024.
[14]Su TS,Liang P,Liang J,et al. Long-term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys,2017,98(3):639-646.DOI:10.1016/j.ijrobp.2017.02.095.
[15]Wang WH,Wang Z,Wu JX,et al. Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels[J].Liver Int,2015,35(12):2603-2610.DOI:10.1111/liv.12857.
[16]Llovet JM,Brú C,Bruix J.Prognosis of hepatocellular carcinoma:the BCLC staging classification[J].Semin Liver Dis,1999,19(3):329-338.DOI:10.1055/s-2007-1007122.
[17]Gomaa AI,Hashim MS,Waked I.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt[J].PLoS One,2014,9(3):e90929.DOI:10.1371/journal.pone.0090929.
[18]Zeng ZC,Seong J,Yoon SM,et al. Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7^th Asia-pacific primary liver cancer expert meeting[J].Liver Cancer,2017,6(4):264-274.DOI:10.1159/000475768.